The emerging role of hypoxia and environmental factors in inflammatory bowel disease
Toxicological Sciences · 01.04.2024 · 198 (2) · 169-184
DOI: 10.1093/toxsci/kfae004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxicological Sciences, online erschienen am 10.01.2024. Verfasst von Luke B Villareal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic and debilitating disorder characterized by inflammation of the gastrointestinal tract. Despite extensive research, the exact cause of IBD remains unknown, hampering the development of effective therapies. However, emerging evidence suggests that hypoxia, a condition resulting from inadequate oxygen supply, plays a crucial role in intestinal inflammation and tissue damage in IBD. Hypoxia-inducible factors (HIFs), transcription factors that regulate the cellular response to low oxygen levels, have gained attention for their involvement in modulating inflammatory processes and maintaining tissue homeostasis. The two most studied HIFs, HIF-1α and HIF-2α, have been implicated in the development and progression of IBD. Toxicological factors encompass a wide range of environmental and endogenous agents, including dietary components, microbial metabolites, and pollutants. These factors can profoundly influence the hypoxic microenvironment within the gut, thereby exacerbating the course of IBD and fostering the progression of colitis-associated colorectal cancer. This review explores the regulation of hypoxia signaling at the molecular, microenvironmental, and environmental levels, investigating the intricate interplay between toxicological factors and hypoxic signaling in the context of IBD, focusing on its most concerning outcomes: intestinal fibrosis and colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131, USA.
ORCID-Profile: Xiang Xue
Förderung
- NIMHD NIH HHS
- NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- NIEHS NIH HHS
- NIAID
- Biology of Infectious Disease and Inflammation
- National Institutes of Health
Zitieren
APA
Villareal, L. B., & Xue, X. (2024). The emerging role of hypoxia and environmental factors in inflammatory bowel disease. Toxicological Sciences, 198(2), 169-184. https://doi.org/10.1093/toxsci/kfae004
Vancouver
Villareal LB, Xue X. The emerging role of hypoxia and environmental factors in inflammatory bowel disease. Toxicological Sciences. 2024;198(2):169-184. doi:10.1093/toxsci/kfae004
BibTeX
@article{Villareal2024,
author = {Villareal, Luke B and Xue, Xiang},
title = {The emerging role of hypoxia and environmental factors in inflammatory bowel disease},
journal = {Toxicological Sciences},
year = {2024},
volume = {198},
number = {2},
pages = {169--184},
doi = {10.1093/toxsci/kfae004}
}
EUVIMED